Knowledge about the impact of menopausal hormone therapy (MHT) on the risk of ovarian cancer (OvC) is insufficient, and studies are inconsistent. Mortality from OvC ranks highest among cancer sites in female reproductive organs. We performed meta-analyses to assess the impact of specified types of MHT on the risk of OvC in cohort studies (CS), case-control studies (CCS), randomized controlled trials (RCT) and cancer registry studies (CRS). We used data published 1966-2006 on estrogen therapy (ET), estrogen/progestin therapy (EPT) or MHT (unspecified regimen) identified by a structured, computerized and manual literature search. We identified 42 studies (30CCS, 7CS, 1 RCT and 4 CRS) with 12 238 cases. The risk of OvC (ever-use, annual risk) is increased 1.28-fold by ET [confidence interval (CI) 1.18-1.40] and 1.11-fold by EPT (CI 1.02-1.21) with a suggestion of greater risks with ET. There appears to be no differential impact of any therapy on histological subtypes. Risks were greater in European than North American studies for both ET and EPT. In conclusion, ET as well as EPT, are risk factors for OvC. Given the widespread use of MHT, known benefits should be weighed against the increased risk of OvC, and more studies are warranted, particularly on factors with the greatest apparent risks.

We conducted meta-analyses to assess the impact of menopausal hormone therapy (MHT) on the risk of incident invasive breast cancer (BC) in cohort studies (CS), case-control studies (CCS) and randomized controlled trials (RCTs) published 1989-2004. We used published data providing information upon unopposed estrogen therapy (ET), estrogen-progestin therapy (EPT) or all MHT combined. Major outcomes were MHT-associated overall risk of BC and change of risk per year used. There is a linear increase of overall risk by midterm year of case ascertainment based upon data of all study types for MHT and to a larger extent for EPT, not for ET. Effects are larger in CS than in CCS. Meta-analyses stratified by <1992 versus > or =1992 as midterm year of case ascertainment indicate larger summary risks for the latter period for all MHT analysed, in particular for EPT. Annual increases in BC risk for EPT across study types are 0-9%, for ET 0-3%. In conclusion, there is evidence that relative risks for BC risks by MHT, in particular EPT, have been increasing in recent years. Given the widespread use of MHT, and often long duration, more detailed knowledge about differential BC risks of both estrogens and progestins are necessary to minimize BC risk in symptomatic women who consider MHT.

No abstract

Aim To investigate the impact of aircraft noise on prescription prevalences of cardiovascular drugs in the vicinity of a major German airport with respect to social gradients. Methods Spatial aircraft noise level data were derived from all individual flight data of Cologne-Bonn Airport for the year 2004, utilizing those 6 months with highest air traffic density. Individual prescription data of 809,379 persons insured with compulsory sickness funds were linked to address-specific noise data (air traffic, road traffic, train traffic). Multivariate logistic analyses were conducted on quartiles of night-time aircraft noise (3.00-5.00 a.m.), adjusting among others for noise from other sources, age, density of nursing homes and stratifying by quartiles of prevalence of social welfare recipients in community quarters.Results Increases of prescription prevalences in general were more pronounced in females. Analyses showed moderate noise-dependent increases of odds ratios for antihypertensive drugs and cardiovascular drugs. More pronounced effects were seen for those persons who received prescriptions for drugs from different groups of drugs (antihypertensive drugs and cardiovascular drugs, antihypertensive and cardiovascular drugs and anxiolytic drugs). In the latter group odds ratios reached maximum values of 3.733 (95% confidence interval: 2.505-5.563) in males and of 3.941 (95% confidence interval: 3.107-4.998) in females. Increases were found in all social strata. Conclusion Night-time aircraft noise increases the prevalence of prescriptions for antihypertensive and cardiovascular drugs, especially when prescribed combined and in conjunction with anxiolytic drugs.

Microsieves are advanced filtration membranes characterized by a uniform pore size, a high pore density, and a thickness smaller than the pore diameter. The uniform pore size provides a high selectivity; the small thickness gives rise to a high flux and allows efficient removal of any filter cake by backflushing. However, microsieves are sensitive to mechanical stress. Thus, they need either an external macroporous support or a hierarchical structure that provides an integrated supportive structure. We prepare microsieves with a hierarchical pore structure by creating breath figure patterns within layers of solutions of polymers in a volatile solvent that are spread out on top of structured supports. For the formation of breath figure patterns, the volatile solvent is evaporated in a moist atmosphere. This cools the surface to such an extent that dew droplets form on the thin film, partially penetrate into the layer, and create a concave imprint in the final solid polymer layer. This procedure is usually done on flat surfaces; in our case the spreading of the polymer solution is done on a support decorated with protrusions. In this procedure, the dew droplets touch the protrusions of the structured support before the polymer solution vitrifies. At the same time, the trenches of the structured substrate are filled with polymer much deeper than the penetration depth of the dew droplets. After the separation of the vitrified layer from the substrate, we obtain thin polymer membranes with a hierarchical structure consisting of an ultrathin active separation layer with submicrometer pores and a supporting layer with larger pores.